Nicholas Koh

Nick Koh is a Senior Associate at 65 Equity Partners, where involvement includes minority, co-control, or majority partnership equity investments and structured equity within the healthcare, consumer, industrials, and business services sectors as part of the Europe investment team. Prior to this role, Nick served as an Investment Banking Associate at Jefferies, contributing to significant M&A transactions, including the sales of Neuraxpharm, Rodenstock, IVC Evidensia, and Viroclinics. Nick holds a Master of Arts degree in Economics from the University of Glasgow, obtained in 2018.